Lemsip Chesty Cough (Guaifenesin)

Guaifenesin increases the volume of secretions in the airways while reducing their viscosity. By hydrating the mucus, it becomes less thick and easier for ciliary movement and coughing effort to transport it out of the lungs, thereby facilitating expectoration.

The appropriate dose of Lemsip Chesty Cough is determined by a healthcare professional based on the patient’s age, weight, and clinical condition. Patients should follow the prescriber’s instructions and the product label for dosing guidance.

Safety data for guaifenesin in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider to weigh potential benefits against any possible risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Lemsip Chesty Cough contains guaifenesin, the most widely used expectorant for mucus thinning. Compared with other classes such as mucolytics (e.g., acetylcysteine), guaifenesin primarily increases airway fluid volume, offering a well‑tolerated option for mild to moderate chesty coughs.

Store the product at room temperature below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Keeping the medication in a dry, cool place helps maintain its stability and effectiveness.

Lemsip Chesty Cough is taken orally, usually as a tablet or liquid preparation, as directed by a healthcare professional. It should be swallowed with a full glass of water, and the dosage schedule should be followed precisely.

Serious adverse reactions are rare but may include allergic responses such as hives, swelling, anaphylaxis, severe skin reactions like Stevens‑Johnson syndrome, and bronchospasm. Patients experiencing any of these symptoms should seek immediate medical attention.

Individuals with a known hypersensitivity to guaifenesin or any component of the formulation should avoid using the product. Additionally, patients with severe renal impairment or those taking medications that may interact significantly should consult a healthcare provider before use.